Related by context. All words. (Click for frequent words.) 74 Non Alcoholic Fatty 74 familial amyloidotic polyneuropathy FAP 74 complement inhibitor eculizumab 73 Pooled Analysis 73 Thiazolidinediones 73 Prospective Randomized 73 Lymphocytic 73 Bronchiectasis 73 Leukemias 73 metastatic malignant 73 Nonalcoholic Fatty Liver Disease 72 Controlled Trial 72 Oral Fingolimod 72 Am J Clin 72 Inflammatory Markers 72 AVAPRO 72 Primary Hypercholesterolemia 72 Levels Linked 72 Adjuvant Chemotherapy 72 Ischemic 72 Hypertrophy 71 J Am Coll 71 Adenomas 71 Combination Treatment 71 Severe Sepsis 71 Meets Primary Endpoint 71 See CLINICAL PHARMACOLOGY 71 Phase 2a Clinical Trial 71 Subgroup Analysis 71 Study Evaluating 71 Subtypes 71 Drug Prevents 71 hypertrichosis occurred 71 IN PATIENTS WITH 71 Inhaled Corticosteroids 71 Placebo Controlled Study 71 Phase 2b Trial 71 Newly Diagnosed Multiple Myeloma 71 Secondary Hyperparathyroidism 71 Ischemic Stroke 71 Ribavirin causes 71 By JENNIFER LEARN 71 leukemia AML 70 hypophosphatemia 70 See WARNINGS 70 Neovascular Age Related Macular 70 treat benign prostatic 70 Fracture Risk 70 Lowers Risk 70 Myelodysplastic Syndrome MDS 70 Eur J 70 Thromboembolic 70 cause cardiac channelopathies 70 Diabetic Neuropathy 70 Fungal Infections 70 Septic Shock 70 chronic thromboembolic pulmonary 70 Double Blind Randomized 70 Demonstrates Efficacy 70 Adjuvant Treatment 70 occlusion CRVO 70 CYP#A# CYP#D# 70 Complicated Skin 70 Polymorphisms 70 Autoantibodies 70 ACE Inhibitors 70 J Am Acad 70 Orthostatic Hypotension 70 Thromboembolism 70 Orthop Surg 70 Mg Usa 70 Prolongs Survival 70 Mg Uk 70 Respiratory Distress 70 Phase 2b Clinical Trial 70 relapsed MM 70 Papillary 70 Effectively Treats 70 SGPT 69 Hypercholesterolemia 69 Proteinuria 69 Systemic Sclerosis 69 FDA APPROVES 69 Pediatric Patients 69 Heterozygous Familial Hypercholesterolemia 69 Liver Failure 69 Hormone Refractory Prostate Cancer 69 Ranolazine 69 Myelofibrosis 69 Chronic Sinusitis 69 myelodysplastic myeloproliferative diseases 69 chronic eosinophilic leukemia 69 Nilotinib 69 Community Acquired Pneumonia 69 Phase IIa Clinical Trial 69 Atypical Hemolytic Uremic Syndrome 69 Subarachnoid hemorrhage 69 Rheumatoid 69 Trial Evaluating 69 J Shoulder Elbow 69 Placebo Controlled 69 Knee Osteoarthritis 69 Thrombotic 69 Tiotropium 69 disease GERD 69 Relapsing Multiple Sclerosis 69 leiomyomas 69 myeloproliferative neoplasms 69 J Am Soc 69 Nat Clin Pract 69 J Clin 69 Peripheral Arterial 69 Phase IIb Trial 69 Critical Limb Ischemia CLI 69 Intracranial Aneurysms 69 J Foot Ankle 69 hyperplasia BPH 69 Demonstrates Positive 69 Treating Chronic 69 Chronic Bronchitis 69 Subclinical 69 Parathyroid Hormone 69 Renal Cell Carcinoma 69 Elderly Patients 69 Vaginal Gel 69 Acute Renal Failure 69 Catheter Associated 69 Metastatic Prostate Cancer 69 Controlled Study 69 Cognitive Impairment 69 Investigational Treatment 69 hypercalciuria 69 Philadelphia Chromosome Positive 69 Prognostic Factors 69 Nonalcoholic fatty liver 69 Allergic Rhinitis 68 hepatorenal syndrome 68 Free Full Text 68 Slow Progression 68 Endothelial Function 68 Bosutinib 68 Herpes zoster 68 Carcinomas 68 HeFH 68 Chronic Heart Failure 68 myocardial infarction ventricular fibrillation 68 Follicular Lymphoma 68 Soft Tissue Sarcoma 68 lupus erythematosus 68 Systemic lupus erythematosus SLE 68 TNF Tumor Necrosis Factor 68 Improves Outcomes 68 keloid scarring 68 Randomized Double blind 68 Clinical Outcome 68 Antitumor Activity 68 CYT# potent vascular disrupting 68 Malignant Melanoma 68 Syndr 68 Basal Cell 68 Bronchopulmonary Dysplasia 68 Subtype 68 Peginterferon Alfa 2a 68 Nephrol 68 hepatic cirrhosis 68 II Clinical Trial 68 Relapsing Remitting Multiple Sclerosis 68 Shows Promise Against 68 Acute Exacerbations 68 Artery Disease 68 Chronic Myeloid Leukemia 68 Naive Patients 68 PAOD 68 ara C 68 Dose Ranging Study 68 Novel Oral 68 Hyperparathyroidism 68 J Pediatr 68 Patients Receiving 68 Often Misdiagnosed 68 IDDM 68 Prostatic 68 STRATEGY FOR AN OPEN 68 Patients Treated With 68 homozygous familial hypercholesterolemia 68 bullous 68 atypical Hemolytic Uremic Syndrome 68 induce orthostatic hypotension 68 Randomized Study 68 Chronic HCV 68 FASEB J. 68 Phase 2b Study 68 TO AVOID PREGNANCY WHILE 68 Systemic lupus erythematosus 68 Lupus Nephritis 68 Attenuates 68 chronic myeloid 68 Phase IIb Clinical Trial 68 Allogeneic 68 Randomized Controlled Trials 68 Squamous 68 CTAP# 68 Unfractionated Heparin 68 Treated Patients 68 Antidepressants Linked 68 systemic juvenile idiopathic 68 Adjunctive Therapy 68 Central Retinal Vein 68 Hormone Receptor Positive 68 #-# Full Text 68 Acute Coronary 68 hip osteonecrosis avascular 68 Patients Undergoing 68 INSPIRE Trial Phase III 68 Safinamide 68 Infarct 68 Refractory Hodgkin Lymphoma 68 Cardiol 68 J Allergy Clin 68 hyperlipemia 68 Double Blind Placebo 68 BCG refractory carcinoma 67 Prophylactic Treatment 67 Relapsing 67 Keratitis 67 Phase Ib Clinical Trial 67 grade squamous intraepithelial 67 Advanced Renal Cell 67 Nephrol Dial Transplant 67 Hypertensive Patients 67 Placebo Controlled Trial 67 Lubiprostone 67 Atopic Dermatitis 67 Treatment Shows Promise 67 Crit Rev 67 nonalcoholic steatohepatitis 67 Morquio 67 Biol Phys 67 Resistant Hypertension 67 Bacterial Vaginosis 67 Angiotensin Converting Enzyme 67 Gene Linked 67 Hypotension 67 Nephropathy 67 Atherosclerotic 67 Disord 67 Skeletal Muscle 67 Soy Isoflavones 67 Hypertriglyceridemia 67 diabetes dyslipidemia 67 Leukopenia neutropenia 67 SGOT 67 Dehydrogenase 67 Cardiotoxicity 67 Esophagitis 67 Curr Opin 67 Epstein Barr Virus EBV 67 Juvenile Idiopathic Arthritis 67 Trandolapril 67 Idiopathic 67 atrophic gastritis 67 Invasive Breast Cancer 67 Multicenter Randomized Double 67 Chronic Constipation 67 Therapeutic Effects 67 Venous Thromboembolism 67 hyperphenylalaninemia HPA due 67 Left Ventricular 67 Sezary syndrome 67 Microalbuminuria 67 Disease Progression 67 Dermatol 67 Asymptomatic 67 Chronic Hepatitis B 67 ANCA associated 67 5q MDS 67 Proc Am Soc 67 erythematosus 67 Randomized Phase II 67 purpura ITP 67 Rheumatoid Arthritis Patients 67 Aortic Stenosis 67 Advanced Melanoma 67 Single Dose 67 Relapsed Refractory 67 Chronic Renal Failure 67 Antiplatelet 67 Mycophenolate Mofetil 67 Acute Bacterial Sinusitis ABS 67 Squamous Cell Carcinoma 67 deep venous thromboses 67 unstable angina pectoris 67 included exfoliative dermatitis 67 Combo Therapy 67 Overactive Bladder 67 herpes zoster shingles 67 SUFFERING FROM 67 Acute Liver Failure 67 Cardiac Resynchronization 67 onset diabetes mellitus 67 HBeAg negative 67 Systematic Review 67 acute humoral rejection 67 Cholesterol Lowering Drug 67 nortriptyline Pamelor 67 Shows Promising 67 induced macular edema 67 TUMORS 67 Renal Anemia 67 Valvular 67 Predict Risk 67 hypereosinophilic syndrome 67 Obstet Gynecol 67 Hyperglycemia 67 Ischaemic 67 Myeloid 67 beta 1a 67 Limb Ischemia 67 Adenocarcinoma 67 diabetes mellitus DM 67 Neovascular AMD 67 CP CPPS 67 Decitabine 67 Glioblastoma Multiforme 67 diarrhea vomiting rash 67 Etanercept 67 Hemorrhagic 67 Virus Linked 67 Hepatotoxicity 67 Escherichia coli Klebsiella pneumoniae 67 Prevent Heart 67 Endometrial Cancer 67 ALN HPN 67 Lymphoid 67 Benign Prostatic Hyperplasia 67 Hepatic Encephalopathy 67 myelofibrosis polycythemia vera 67 mixed hyperlipidemia 67 torsade de pointes 67 Endocrinol 67 Treatment Resistant 67 Growth Hormone Deficiency 67 sitaxsentan 67 hyperparathyroidism 67 Bosentan 67 Myeloma Patients 67 ANN INTERN MED 67 Sleep Disturbances 67 Drug Combo 67 INTEGRILIN R 67 B Cell Lymphoma 67 Mouse Models 67 Chronic Hepatitis C 67 Syncria R 67 Intracerebral 67 reflux esophagitis 67 dasatinib Sprycel ® 67 heparin induced thrombocytopenia 67 collagenous colitis 67 See CONTRAINDICATIONS 67 TTR amyloidosis 67 neurological manifestations 67 Erythema 67 Antigen Specific 67 Sevelamer 67 imipramine Tofranil 67 hyperhomocysteinemia 67 ACTEMRA TM 67 ergot derivatives 66 Phase 2a Trial 66 relapsed Acute Myeloid 66 somatostatin analog 66 Appears Safe 66 Exacerbations 66 Meta Analysis 66 Adjunctive 66 Obesity Linked 66 PLX STROKE targeting 66 Randomized Phase 66 Streptococcus pneumoniae Haemophilus influenzae 66 Slows Progression 66 Chronic Pelvic Pain 66 Preclinical Models 66 hypovitaminosis D 66 Novel Inhibitor 66 PREZISTA r arm 66 abacavir Ziagen 66 Irritable Bowel 66 HIV HCV coinfected 66 Int J Obes Relat 66 Insulin Sensitivity 66 Pharmacokinetic Study 66 Improves Survival 66 PEGINTRON TM 66 Cholinesterase Inhibitors 66 Ovarian Cancers 66 Crit Care Med 66 Tezampanel 66 SSc 66 Adenoviral 66 Nonalcoholic Steatohepatitis 66 nonalcoholic steatohepatitis NASH 66 haloperidol Haldol 66 Interferon Beta 66 ADPKD 66 bacterial prostatitis 66 gastric adenocarcinoma 66 Prognostic Significance 66 Intravitreal 66 Cognitive Decline 66 Transdermal Patch 66 ST Elevation Myocardial 66 CLINICAL PHARMACOLOGY 66 Mylan Receives Approval 66 recurrent glioblastoma multiforme 66 Peginterferon 66 Fatty Liver Disease 66 Seasonal Allergic Rhinitis 66 IS ASSOCIATED WITH 66 Arrhythmogenic 66 Cystic 66 Chronic Prostatitis 66 AA Amyloidosis 66 Gastrointestinal Tract 66 Nebulized 66 polyarticular 66 Heart Failure Patients 66 Gene Variant 66 candesartan cilexetil 66 Cutaneous T 66 HEART FAILURE 66 Arterial Disease 66 Randomized Clinical Trial 66 Renal Artery 66 enterocolitis 66 Cyclooxygenase 2 66 Polyneuropathy 66 Idiopathic Pulmonary Fibrosis 66 Arch Neurol 66 PEGylated Fab fragment 66 systemic autoimmune 66 EQUIP OB 66 Benign prostatic hyperplasia BPH 66 Acute Pancreatitis 66 bronchial hyperresponsiveness 66 Drug Candidate 66 Endocarditis 66 C1 INH deficiency 66 Combination REOLYSIN R 66 Systemic Lupus Erythematosus 66 R lenalidomide 66 Peptide YY 66 Azacitidine 66 Breast Cancer Recurrence 66 Previously Treated 66 benign prostatic hypertrophy BPH 66 Chronic Lymphocytic Leukemia 66 Idiopathic pulmonary fibrosis 66 Glioma 66 transthyretin TTR mediated amyloidosis 66 systolic hypertension 66 Protease Inhibitor 66 Myocardial Ischemia 66 Nesiritide 66 Diffuse Large B 66 TMC# C# 66 Premenopausal Women 66 Serious Infections 66 CLINICAL STUDIES 66 Castration Resistant Prostate Cancer 66 Ankylosing spondylitis 66 dual endothelin receptor antagonist 66 Initiate Phase 66 hypercholesterolaemia 66 Esophageal 66 Left Ventricular Hypertrophy 66 metastatic neuroendocrine tumors 66 Pharmacokinetics PK 66 venlafaxine Effexor 66 toenail onychomycosis 66 pregnancy bacterial vaginosis 66 VASCULAR 66 MELAS 66 GOUT 66 Randomized Double Blind 66 Hepatocellular 66 Arch Facial Plast 66 Coronary Artery Bypass Graft 66 Cutaneous Melanoma 66 pathophysiological effects 66 Intracerebral Hemorrhage 66 serum triglycerides 66 Unresectable 66 Atomoxetine 66 HMG CoA reductase inhibitors 66 FDA Approvals 66 Bipolar Mania 66 BARACLUDE ® 66 hypocalcaemia 66 Arch Intern Med 66 leukemia ALL 66 Severe Asthma 66 proctitis 66 Randomized Double Blind Placebo 66 Int J Radiat Oncol 66 Renal dysfunction 66 Carotid Revascularization Endarterectomy vs. 66 diarrhea predominant irritable 66 Blind Placebo Controlled Trial 66 Genes Predict 66 RENAL 66 Bone Metastases 66 Statistically Significant 66 Teriflunomide 66 TREATMENT FOR 66 Uterine Cancer 66 Patency 66 Gastric Ulcers 66 Am J Cardiol 66 Eur J Endocrinol 66 Exacerbation 66 Prostate AdenoCarcinoma Treatment 66 Completes Patient Enrollment 66 Parnate 66 anterior uveitis 66 Renal Impairment 66 Tigecycline 66 serum leptin 66 Neurosurg 66 Bucindolol 66 Blepharospasm 66 Demonstrate Significant 66 Progressive Multifocal Leukoencephalopathy 66 N Engl J 66 Coronary Arteries 66 FEMALES SHOULD BE ADVISED 66 Genes Linked 66 Valopicitabine 66 Systemic Lupus Erythematosus SLE 66 Unstable Angina 66 quetiapine Seroquel 66 GH deficiency 66 Chemotherapy induced 66 Stomatitis 66 neutropenia thrombocytopenia 66 Phase III Clinical Trial 66 Hyperlipidemia 66 Increased Mortality 66 Adjuvant Therapy 66 severe hepatomegaly 66 HYPERTENSION 66 Initiates Clinical Trial 66 Peritonitis 66 NDA Submission 66 endometrial hyperplasia 66 lexidronam injection 66 PATIENTS WITH 66 Improve Survival 66 Diabetic Nephropathy 66 lichen planus 66 cheilitis 66 First Patient Dosed 66 grade cervical intraepithelial 66 Multiple Myeloma MM 66 Comorbidities 66 Sapacitabine 66 Completes Enrollment 66 Hepatocellular Carcinoma 66 Metab Disord 66 surgically resected 66 NASH Huntington 66 elevated triglyceride levels 66 colorectal adenoma 66 Neovascularization 66 Preclinical Study 66 PLEASE READ THE FOLLOWING 66 AVONEX ® 66 Metastases 66 TO TREAT 66 Bronchodilator 66 severe malignant osteopetrosis 66 Critically Ill Patients 66 novel VDA molecule 66 bladder carcinoma 65 antiphospholipid syndrome 65 Pivotal Phase III 65 cytomegalovirus infection 65 Clin Oncol 65 FUSILEV enhances 65 Plus Ribavirin 65 parathyroid carcinoma 65 Randomized Controlled 65 ABCB1 65 post transplant lymphoproliferative 65 INFECTIONS 65 Osteoporosis Drugs 65 Generalized Anxiety Disorder 65 Non inferiority 65 cough dyspnea 65 cisplatin gemcitabine 65 First Patient Enrolled 65 Stent Restenosis 65 neutropenia dehydration dyspnea 65 Is Well Tolerated 65 aplastic anemia AA 65 included neutropenia anemia 65 Nutr 65 Generalized Anxiety Disorder GAD 65 headache abdominal pain 65 albiglutide currently 65 Polymorphic Ventricular Tachycardia CPVT 65 precursor acute lymphoblastic 65 Enlarged Prostate 65 Malignant Glioma 65 Glimepiride 65 Dilated Cardiomyopathy 65 Aggressive Prostate Cancer 65 stage IIIB 65 macular edema secondary 65 cyclophosphamide methotrexate 65 J Nutr 65 angiotensin receptor blockers ARB 65 Non Invasive Treatment 65 Demonstrated Significant 65 cell lymphoma CTCL 65 oropharyngeal candidiasis OPC 65 Hepatitis B Virus 65 Erythropoietic therapies may 65 metaplasia 65 Viral Load 65 reflux disease GERD 65 chronic idiopathic 65 C Reactive Protein 65 SPRYCEL ® 65 Venous thromboembolism 65 Neurol 65 erosive gastritis 65 Child Adolesc Psychiatry 65 Acute Decompensated Heart Failure 65 Angioedema 65 Pediatr 65 Gene Mutation Linked 65 Ibritumomab Tiuxetan 65 unfractionated heparin UFH 65 Non Responders 65 Duodenal 65 Brain Shrinkage 65 Captopril 65 Antiviral Therapy 65 Colorectal Adenomas 65 Multicenter Trial 65 Investigational Compound 65 arthritis PsA 65 Janus kinase 65 selective modulator 65 doi #.#/fj.#-# 65 LENALIDOMIDE 65 Hypoactive Sexual Desire Disorder 65 Alanine 65 thyrotoxicosis 65 impaired glucose metabolism 65 Therapy Improves 65 Chronic lymphocytic leukemia 65 dermatologic reactions 65 Diabetic Foot Ulcer 65 Test Detects 65 Placebo controlled 65 Achieves Primary Endpoint 65 2 methoxyestradiol 65 cystic fibrosis chronic pancreatitis 65 hay fever allergic rhinitis 65 triglycerides TG 65 Sipuleucel T 65 brand ciclesonide HFA 65 T2DM 65 oral dual endothelin 65 Vertebral Fractures 65 malignant neoplasm 65 Respiratory Syncytial Virus 65 Acute Myeloid Leukaemia AML 65 Genetic Variant 65 SIDE EFFECTS CHEAP ONLINE 65 Paraplatin ® 65 Etiology 65 Liver Injury 65 Fatty liver 65 THERAPY FOR 65 NS5B polymerase 65 Zollinger Ellison syndrome 65 Leber Hereditary Optic Neuropathy 65 Autologous Stem Cell Transplantation 65 Endocrinol Metab 65 Patients Suffering 65 Cilostazol 65 Rhinosinusitis 65 Pivotal Phase 65 mild renal insufficiency 65 Polymerase Inhibitor 65 Lanthanum Carbonate 65 atypical hemolytic uremic syndrome 65 BENICAR HCT 65 Genetic Variation 65 FDA Approves Drug 65 Drug Shows Promise 65 Bacteremia 65 Cancer Incidence Mortality 65 Uric Acid 65 metastatic castration resistant 65 non alcoholic steatohepatitis 65 optic neuropathy 65 lipid elevations 65 invasive aspergillosis 65 Demonstrates Significant 65 Node Positive 65 Pelvic Organ Prolapse 65 Coronary Artery 65 Acute Myocardial 65 Epithelial Cell 65 Reflux Disease 65 Renal Insufficiency 65 Apolipoprotein E 65 Nodules 65 Stent Thrombosis 65 WE WILL CONTINUE TO 65 Intravenous immunoglobulin 65 vaginal candidiasis 65 Shows Statistically Significant 65 LymphoStat B belimumab 65 progressive neurodegenerative disorder 65 CIMZIA TM certolizumab pegol 65 J Cataract Refract 65 Neoadjuvant 65 subependymal giant cell 65 Enzyme Replacement Therapy 65 Neoplasms 65 Multicentre 65 Demonstrates Sustained 65 Invasive Fungal Infections 65 Metastatic Renal Cell Carcinoma 65 Eculizumab 65 Aortic stenosis 65 evaluating mipomersen 65 Multicenter Randomized 65 Diabetic Macular Edema 65 INCB# [003] 65 Mortality Risk 65 Novel Mechanism 65 Liver Tumors 65 Hyperphosphatemia 65 Aurora Kinase 65 autosomal recessive disorder 65 Signaling Pathway 65 Cardiovascular Outcomes 65 Abstract Full Text 65 urate oxidase 65 secondary hyperparathyroidism 65 Oral Cladribine 65 Thrombocytopenia 65 Treat Anemia 65 Enzastaurin 65 Hypertensive 65 elevated lipase 65 Plaque Psoriasis 65 pulmonary hypertension PH 65 HDAC Inhibitor 65 Surgical Treatment 65 Chronic Fatigue Syndrome CFS 65 Immune Responses 65 Pulmonary Arterial Hypertension 65 Squamous Cell 65 methicillin susceptible Staphylococcus aureus 65 multicenter randomized placebo controlled 65 pan histone deacetylase 65 metastatic GIST 65 Carotid Stenting 65 protein tyrosine phosphatase 1B 65 Rare Genetic 65 kidney urologic 65 BY SUE KIESEWETTER 65 Randomized Controlled Trial 65 Protein Linked 65 null mice 65 CLINICAL TRIAL 65 Lamotrigine 65 ST Segment Elevation 65 Genetic Mutation 65 essential thrombocythemia ET 65 Infusion Reactions Severe 65 Glatiramer Acetate 65 Muscle Cells 65 Percutaneous Tibial Nerve Stimulation 65 Epidermal Growth Factor Receptor 65 Bulimia Nervosa 65 alfa 2a 65 R Saizen R 65 progressive dyspnea 65 Carcinoid tumors 65 idiopathic PAH 65 Maleate 65 Pafuramidine 65 Immunol 65 invasive candidiasis 65 Recurrent Breast Cancer 65 Therapy Reduces 65 Dose Response 65 #:#-# [031] 65 PEGylated anti 65 ® lenalidomide 65 phenothiazines 65 polycythemia vera essential thrombocythemia 65 TREATMENT OF 65 dilated cardiomyopathy DCM 65 Radiographic findings 65 Stress Incontinence 65 choroidal neovascularization 65 Immunotherapeutic 65 non splenectomized 65 Hosp Epidemiol 65 Heart Circ Physiol 65 Polycystic ovary syndrome PCOS 65 Factor Receptor 65 Acute Myocardial Infarction 65 Hyperkalemia 65 Diabetic Foot Ulcers 65 brivanib 65 CHEAP ONLINE PHARMACY BEST 65 orally administered inhibitor 65 Fibrosis 65 Fondaparinux 65 methylenetetrahydrofolate reductase 65 Radiofrequency Ablation 65 Prevent Strokes 65 ILLNESSES 65 Nymox NX 65 ertapenem 65 Ann Oncol 65 Beta Blocker 65 PsA 65 Relapsed Multiple Myeloma 65 Randomized Placebo Controlled 65 erlotinib Tarceva ® 65 primary hyperparathyroidism 65 chronic myocardial ischemia 65 Postmenopausal Osteoporosis 65 Obese Patients 65 dysglycemia 65 Successfully Completes Phase 65 BY DAVE VAN 65 Hypertrophic 65 immunocompetent patients 65 Left Ventricular Dysfunction 65 Prospective Cohort Study 65 8mg/kg 65 Fatty Liver 65 Adiposity 65 HUMIDITY WILL 65 CASES IN 65 Hepatic 65 Prevalence Worldwide 65 Gynecol 65 cirrhosis liver failure 65 underlying vasculopathy 65 Peptic Ulcer 65 Mol Cell 65 Chemoradiation 65 Phospholipase A2 65 Kidney Int 65 Cognitive Deficits 65 Pioglitazone 65 SUPPRELIN R LA 65 Rotavirus Vaccine 65 includes S. anginosus 65 ARCALYST ® rilonacept 65 Genetic Markers 65 COPEGUS R 65 Scandinavian Simvastatin Survival 65 Chemotherapy Induced 65 Orally administered 64 Coronary Artery Calcium 64 Glufosfamide 64 Physician Insights 64 Hematological 64 interstitial fibrosis 64 Hospital Acquired Pneumonia 64 gastro esophageal reflux disease 64 Clinical Trial Results 64 adjunctive placebo 64 papillary renal cell carcinoma 64 mL/min/#.# m 2 64 prostate TURP 64 Nat Genet 64 Eprodisate 64 juvenile idiopathic arthritis JIA 64 Darapladib 64 Severe Primary IGFD 64 Infect Dis 64 Treatment Reduces 64 NIDDM 64 LHON 64 chronic granulomatous disease 64 Long Term Efficacy 64 SHPT 64 Systolic Hypertension 64 Fallopian Tube 64 hemodynamically significant 64 Amgen Neulasta R 64 steroid refractory ulcerative 64 idiopathic membranous nephropathy 64 Decompensated 64 endoluminal stent graft 64 del 5q MDS 64 asthenia fatigue 64 giant cell arteritis 64 CHEAP ONLINE PHARMACY LOW 64 Moxifloxacin 64 Arrhythmogenic Right Ventricular Cardiomyopathy 64 polyposis 64 #:#-# [023] 64 Adenoma 64 J Consult Clin 64 candidemia 64 primary hypercholesterolemia 64 Bronchiolitis 64 Endovascular Repair 64 Vasc 64 J Clin Endocrinol Metab 64 PROSTATE 64 Am J Obstet 64 Brain Metastases 64 Infarction 64 Gastric Cancer 64 Renal Function 64 Lowers Blood Pressure 64 Chronic Liver Disease 64 Aeolus Pharmaceuticals Announces 64 sunitinib Sutent ® 64 Epratuzumab 64 Lung Injury 64 Teva Provides Update 64 Decompensated Heart Failure 64 pulmonary alveolar 64 NOMID 64 Am J Respir 64 CTAP# Capsules 64 Peginterferon alfa 2b 64 Benign Prostatic Hyperplasia BPH 64 COLLABORATION WITH 64 von Willebrand Factor 64 Omacetaxine 64 Posaconazole 64 Fixed Dose 64 urothelial carcinoma 64 Improved Survival 64 Treatment Naive 64 Therapeutic Efficacy 64 Lung Cancer Survival 64 histological subtype 64 receptor tyrosine kinase inhibitor 64 Synovial 64 HORMONE 64 5MG TAB 64 FUTURE EVENTS OR 64 Study Showed 64 Immunosuppression 64 Br J 64 Suicidality 64 BRAF V#E 64 chronic idiopathic thrombocytopenic purpura 64 Onychomycosis 64 TORNADO IS 64 Idiopathic Thrombocytopenic Purpura ITP 64 hepatocellular 64 Antiplatelet Therapy 64 colorectal carcinoma 64 Occlusive Disease 64 Infected Patients 64 transcranial Doppler ultrasound 64 LHRH receptor positive 64 5 HT1A receptor 64 THAT ARE DIFFICULT TO 64 haematologic 64 CYP#A# inducers 64 Lung Cancer Trial 64 Triglyceride 64 mU liter 64 Nicotine Vaccine 64 HCV SPRINT 64 oral antidiabetic medication 64 fulminant hepatic failure 64 TNF alpha selectively neutralizing 64 Preterm Delivery 64 Minimally Invasive Treatment 64 Iron Overload 64 RAVEL 64 PERFORM AT 64 diabetic gastroparesis 64 VIIBRYD 64 Linezolid 64 Haptoglobin